112 related articles for article (PubMed ID: 2389490)
1. Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
Da Costa M; Metcalfe S; Calne RY
Transplant Proc; 1990 Aug; 22(4):1945-6. PubMed ID: 2389490
[No Abstract] [Full Text] [Related]
2. Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
Metcalfe SM; Watson CJ; Collier DG; DaCosta M; Friend PJ; Pollard SG; Luddington R; Calne RY
Transplant Proc; 1991 Aug; 23(4):2219-20. PubMed ID: 1871852
[No Abstract] [Full Text] [Related]
3. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
Saumweber DM; Bergmann R; Gokel M; Brecht HM; Hammer C
Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613
[No Abstract] [Full Text] [Related]
4. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
[No Abstract] [Full Text] [Related]
5. The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
Watson CJ; Luddington R; St John Collier DG; Calne RY; Metcalfe SM
Transplantation; 1993 Oct; 56(4):1047-9. PubMed ID: 8212192
[No Abstract] [Full Text] [Related]
6. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
Crawford SE; Huang L; Hsueh W; Takami H; Gonzalez-Crussi F; Backer CL; Mu Y; Liu H; Mavroudis C
J Heart Lung Transplant; 1999 May; 18(5):470-7. PubMed ID: 10363692
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
Makowka L; Chapman FA; Cramer DV; Qian SG; Sun H; Starzl TE
Transplantation; 1990 Sep; 50(3):359-65. PubMed ID: 2402783
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of cardiac allograft survival by suppressor T cells (Ts) generated in vitro using cyclosporine.
Lenrow DA; Markmann JF; Shachner MS; Naji A
Transplant Proc; 1989 Feb; 21(1 Pt 1):473-4. PubMed ID: 2523144
[No Abstract] [Full Text] [Related]
9. In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.
Tesi RJ; Hong J; Butt KM; Jaffe BM; McMillen MA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1382-4. PubMed ID: 3274336
[TBL] [Abstract][Full Text] [Related]
10. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival.
Ozawa T; Kamada N; Ashizawa T; Aoki T; Koyanagi Y; Kimura K
Transplant Proc; 1991 Aug; 23(4):2213-4. PubMed ID: 1871850
[No Abstract] [Full Text] [Related]
12. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts.
Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G
Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514
[No Abstract] [Full Text] [Related]
13. Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys.
Bergmann R; Saumweber DM; Brecht HM; Hammer C
Transplant Proc; 1990 Aug; 22(4):2009-10. PubMed ID: 2389511
[No Abstract] [Full Text] [Related]
14. Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
Teramoto K; Baquerizo A; Imagawa DK; Seu P; Hart J; Dempsey RA; Terasaki PI; Kamada N; Busuttil RW
Transplant Proc; 1991 Feb; 23(1 Pt 1):602-3. PubMed ID: 1990621
[No Abstract] [Full Text] [Related]
15. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
[No Abstract] [Full Text] [Related]
16. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
Harrison PC; Mainolfi E; Madwed JB
J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor.
Foegh ML; Khirabadi BS; Rowles JR; Braquet P; Ramwell PW
Transplantation; 1986 Jul; 42(1):86-8. PubMed ID: 3523888
[No Abstract] [Full Text] [Related]
18. Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection.
O'Hair DP; Roza AM; Pieper GM; Komorowski R; Moore G; McManus RP; Adams MB
Transplant Proc; 1992 Apr; 24(2):702-3. PubMed ID: 1566490
[No Abstract] [Full Text] [Related]
19. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
[No Abstract] [Full Text] [Related]
20. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients.
Hall BM; Gurley KE; Dorsch SE
Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
